Real-World Clinical and Economic Outcomes Associated with Palbociclib for HR-Positive/HER2 Negative Metastatic Breast Cancer: A Commentary

Despite the achieved advancement in pharmacological cancer treatments, the majority of postmenopausal women with hormone receptor-positive metastatic breast cancer (mBC) will experience disease progression. Research into alternative therapies with improved efficacy and reduced side effects has led t...

Descripción completa

Detalles Bibliográficos
Autores principales: Babcock, Aram, Ali, Askal Ayalew, Balkrishnan, Rajesh, Montero, Alberto, Diaby, Vakaramoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391228/
https://www.ncbi.nlm.nih.gov/pubmed/32584682
http://dx.doi.org/10.18553/jmcp.2020.26.7.826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391228/
https://www.ncbi.nlm.nih.gov/pubmed/32584682
http://dx.doi.org/10.18553/jmcp.2020.26.7.826

Ejemplares similares